FEMS CYC202 chemical structure Microbiol Lett 2010, 303:137–146.PubMedCrossRef 19. Bielaszewska M, Zhang W, Tarr PI, Sonntag AK, Karch H: Molecular profiling and phenotype analysis of Escherichia coli O26:H11 and O26:NM: secular and geographic consistency of enterohemorrhagic

and enteropathogenic isolates. J Erastin nmr Clin Microbiol 2005, 43:4225–4228.PubMedCrossRef 20. Bielaszewska M, Middendorf B, Kock R, Friedrich AW, Fruth A, Karch H, et al.: Shiga toxin-negative attaching and effacing Escherichia coli : distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution. Clin Infect Dis 2008, 47:208–217.PubMedCrossRef 21. Bielaszewska M, Kock R, Friedrich AW, von Eiff C, Zimmerhackl LB, Karch H, et al.: Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm? PLoS ONE 2007, 2:e1024.PubMedCrossRef

22. Dopfer D, Sekse C, Beutin L, Solheim H, van der Wal FJ, de BA, et al.: Pathogenic potential and horizontal gene transfer in ovine gastrointestinal Escherichia coli . J Appl Microbiol 2010, 108:1552–1562.PubMedCrossRef 23. Mellmann A, Lu S, Karch H, Xu Jg, Harmsen D, Schmidt MA, et al.: Recycling of Shiga Toxin 2 Genes in Sorbitol-Fermenting Enterohemorrhagic Escherichia coli O157:NM. Appl Environ Microbiol 2008, 74:67–72.PubMedCrossRef 24. Coombes BK, Wickham ME, Mascarenhas M, Gruenheid S, Finlay BB, Karmali MA: Molecular analysis as an aid to assess the public health risk of non-O157 Compound C mouse Shiga toxin-producing Escherichia coli strains. Appl Environ Microbiol 2008, 74:2153–2160.PubMedCrossRef 25. Bugarel M, Beutin L, Scheutz F, Loukiadis E, Fach P: Identification of genetic markers for differentiation

of Shiga toxin-producing, enteropathogenic and avirulent strains of Escherichia coli O26. Appl Environ Microbiol 2011, 77:2275–2281.PubMedCrossRef 26. Bielaszewska M, Prager R, Kock R, Mellmann A, Zhang W, Tschape H, et al.: Shiga Toxin Gene Loss and Transfer In Vitro and In Vivo during Enterohemorrhagic Escherichia coli O26 Infection in Humans. Appl Environ Microbiol 2007, 73:3144–3150.PubMedCrossRef 27. Zuur AF, Ieno EN, Smith GM: Measures of association. In Analysing Ecological Data. Edited by: Gaij M, FAD Krickeberg K, Samet J, Tsiatis A, Wong W. New York: Springer; 2007:163–187. 28. Imamovic L, Tozzoli R, Michelacci V, Minelli F, Marziano ML, Caprioli A, et al.: OI-57, a genomic island of Escherichia coli O157, is present in other seropathotypes of Shiga toxin-producing E. coli associated with severe human disease. Infect Immun 2010, 78:4697–4704.PubMedCrossRef 29. Konczy P, Ziebell K, Mascarenhas M, Choi A, Michaud C, Kropinski AM, et al.: Genomic O island 122, locus for enterocyte effacement, and the evolution of virulent verocytotoxin-producing Escherichia coli . J Bacteriol 2008, 190:5832–5840.PubMedCrossRef 30. Ogura Y, Ooka T, Iguchi A, Toh H, Asadulghani M, Oshima K, et al.